Clinical outcome at 16-year follow-up
| Patients and outcome | No-touch group | Conventional group | p Value* |
|---|---|---|---|
| Included at study start, n | 52 | 52 | |
| Total mortality, n (%) Of which were cardiac related | 13 (25) 4 (8) | 14 (27) 6 (12) | 1.00 |
| Loss to follow-up at 16 years, n | 2 | 1 | |
| Follow-up at 16 years, n | 37 | 37 | |
| Recurrent angina, n (%) | 14 (38) | 17 (46) | 0.68 |
| Acute myocardial infarction, n (%) | 5 (14) | 10 (27) | 0.27 |
| Ischaemia driven cine-angiogram, n (%) | 10 (27) | 13 (35) | 0.64 |
| Percutaneous coronary intervention, n (%) | 8 (22) | 8 (22) | 1.00 |
| Angina-free patients, n (%) | 23 (62) | 20 (54) | 0.85 |
| NYHA-class I, n (%) | 18 (78) | 10 (50) | 0.46 |
*Statistical significance by Fisher's exact test.
NYHA, New York Heart Association.